SLC10A3 and neoplasm: The predictive capacity of SLC10A3 was 0.505 in the whole cohort (Supplementary Figure 5D), 0.507 in the primary tumor cohort (Supplementary Figure 5E) and 0.674 in the recurrent tumor cohort (Supplementary Figure 5F).